Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness

Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness

The Triple Negative Breast Cancer (TNBC) subtype is known to have a more aggressive clinical course compared to other breast cancer subtypes. Targeted therapies for this type of breast cancer are limited and patients are mostly treated with conventional chemo- and radio-therapies which are not speci...

Full description

Bibliographic Details
Main Authors: Rinad Mahmoud, Paloma Ordóñez-Morán, Cinzia Allegrucci
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
triple negative breast cancer
stemness
differentiation
persister cells
phenotype
drug resistance
Online Access:https://www.mdpi.com/2072-6694/14/17/4280

Similar Items

Similar Items